Clinical trial
Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With…
NCT00109733 · EMD Serono, Industry · Completed
Key facts
| NCT number | NCT00109733 |
|---|---|
| Title | Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency |
| Official title | A Phase IIIb, Prospective, Multicenter, Randomized, Open-label Study to Determine the Safety and Efficacy of Two Different Dosing Regimens of Saizen® (Recombinant Human Growth Hormone (r-hGH), Using Cool.Click™ in Subjects With Childhood-onset Growth Hormone Deficiency During the Adolescent… |
| Lead sponsor | EMD Serono, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Childhood-onset Growth Hormone Deficiency, Pituitary Dwarfism |
| Intervention type | Biological |
| Interventions | recombinant human growth hormone |
| Enrollment | 31 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | May 3, 2005 |
| Last update posted | Aug 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: